Home › Therapeutic areas › Renal › APOL1-Mediated Kidney Disease
APOL1-Mediated Kidney Disease (1 companies)
Companies with an active program in APOL1-Mediated Kidney Disease.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| MAZE | Maze Therapeutics | MetabolicRenal Rare | 1 | Phase 2 | $1.90B | 4 |
No companies match.